Progress towards novel therapeutics and diagnostic applications in oncology and rare diseases is reaching new heights with new innovative next-generation sequencing technologies. These include, but are not limited to advancements in bioinformatics, next-generation sequencing for pathogen detection, nanosensor technology for genome sequencing and healthcare diagnostics, molecular indexing technology for digital detection of single cells, and cloud-based accelerated genomic analysis.
A BioPharma Dealmakers webcast hosted on November 29, 2016, featured four innovative and complementary companies and their technologies advancing new possibilities of next-generation sequencing applications. We are particularly excited that BlueBee was presenting as a contributing partner in this webcast, with Hans Cobben, CEO of BlueBee. This webcast provides an excellent opportunity to learn more about the various companies, and also specifically about BlueBee’s Genomics flexible and secure cloud-based solution for high performance computing that is available at an affordable price.
See the webcast to learn more about what solutions are pushing the envelope on next-generation sequencing and its applications.
About the Webcast
BioPharma Dealmakers webcasts are dedicated to small and large companies looking for commercial partnerships. Read the quarterly BioPharma Dealmakers supplement in Nature Biotechnology and Nature Reviews Drug Discovery.